Patent classifications
C07K14/7055
LUNG CANCER DIAGNOSIS MARKER, ANTIBODY AND APPLICATION THEREOF
A human lung cancer marker N3G4, and use of the same as human lung cancer marker is disclosed. Hybridoma cells which produce anti-N3G4 monoclonal antibodies, and the secreted monoclonal antibody LC128, and use of LC128 for the preparation of a diagnostic agent for lung cancer are also disclosed. Kits for in vitro diagnosis comprising the monoclonal antibody LC128 and methods for detecting tumor markers in lung tissue by using the monoclonal antibody LC128 are also disclosed.
CIRCULAR RNA AND USE THEREOF
Provided relates to a circular RNA comprising an internal ribosome entry site (IRES) element, a protein coding sequence and a poly A. Provided also relates to the precursor RNA, the vector and the method for producing the circular, and the use of the circular RNA.
a4ß1/7 INTEGRIN LIGAND CONJUGATED COMPOUNDS AND USES THEREOF
Provided herein are .sub.4.sub.1/7 integrin receptor ligand-containing compounds, methods of delivering said compounds, and methods of treating diseases, disorders, and symptoms (e.g., central nervous system diseases, disorders, and symptoms) in a subject using said compounds.